Biopharmaceutical and chmical firms' R&D disclosure, and cost of equity : the impact of the regulatory regime
Year of publication: |
2014
|
---|---|
Authors: | La Rosa, Fabio ; Liberatore, Giovanni |
Published in: |
European management journal. - Amsterdam : Elsevier, ISSN 0263-2373, ZDB-ID 859497-1. - Vol. 32.2014, 5, p. 806-820
|
Subject: | Intellectual capital | R&D | Disclosure regulation | Discretionary reporting | Equity cost | Unternehmenspublizität | Corporate disclosure | Kapitalkosten | Cost of capital | Regulierung | Regulation | Immaterielle Werte | Intangible assets | Auskunftspflicht | Großbritannien | United Kingdom | Berichtswesen | Reporting |
-
Intellectual capital disclosure : the Greek case
Manolopoulou, Eirini, (2014)
-
Impact of nonfinancial intellectual capital information on investors : evidence from Japan
Motokawa, Katsuhiro, (2014)
-
Brexit disclosure : companies' honest or bogus perceptions of risk?
Vasilescu, Camelia, (2023)
- More ...
-
La Rosa, Fabio, (2018)
-
La Rosa, Fabio, (2017)
-
La Rosa, Fabio, (2018)
- More ...